NEW YORK (GenomeWeb News) — Helicos for the second time in a week ratcheted down its share price for its planned initial public offering, cutting the price of its shares to $9 — a 40-percent drop from the high end of its original plan — according to a filing with the US Securities and Exchange Commission today.
 
Earlier this week, the company cut the price of the 5.4 million shares it is offering to between $10 and $11 per share from an original projection of between $13 and $15 per share, according to an earlier SEC filing.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.